David Abrams acquired 3.81 Million Nuvation Bio shares worth $8 Million. That's 0.12% of their equity portfolio (12th largest holding). David Abrams acquired their 3.81 Million shares in Q1 2021. So far they never sold any shares in the company. The investor's estimated purchase price is $43.7 Million, resulting in a loss of 82%.